APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 130 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $185,158,000 | -5.3% | 2,929,708 | -35.7% | 1.91% | -1.4% |
| Q1 2021 | $195,585,000 | -32.0% | 4,558,029 | -9.4% | 1.93% | -15.5% |
| Q4 2020 | $287,618,000 | +89.6% | 5,028,289 | 0.0% | 2.29% | +99.0% |
| Q3 2020 | $151,703,000 | -7.6% | 5,028,289 | 0.0% | 1.15% | -23.5% |
| Q2 2020 | $164,224,000 | +21.9% | 5,028,289 | 0.0% | 1.50% | -17.3% |
| Q1 2020 | $134,708,000 | -6.0% | 5,028,289 | +7.5% | 1.82% | +1.7% |
| Q4 2019 | $143,249,000 | +27.1% | 4,678,289 | 0.0% | 1.78% | +15.2% |
| Q3 2019 | $112,700,000 | +72.4% | 4,678,289 | +81.3% | 1.55% | +6.0% |
| Q2 2019 | $65,370,000 | +29.9% | 2,579,708 | 0.0% | 1.46% | +4.4% |
| Q1 2019 | $50,304,000 | +71.0% | 2,579,708 | +15.7% | 1.40% | +14.8% |
| Q4 2018 | $29,410,000 | – | 2,229,708 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |